|
David W. Gryska has served as Celgene Corporation’s Senior Vice President and Chief Financial Officer since joining the company in December of 2006. Prior to joining Celgene he was a principal at Strategic Consulting Group where he was responsible for investing and providing strategic consulting to earlier-stage biotechnology companies. From 1998 to 2004 he was Senior Vice President and Chief Financial Officer at SCIOS Inc. From 1993 to 1998 he served as Vice President and Chief Financial Officer of Cardiac Pathways a company later acquired by Boston Scientific Corporation. Prior to Cardiac Pathways Mr. Gryska spent eleven years at Ernst & Young. He holds a B.A. in accounting and finance from Loyola University and an M.B.A. from Golden Gate University. Mr. Gryska also serves as a member of the Board of Directors of Seattle Genetics. | 